Project measures / variables set:   GMC16   ALP

ID, description, units MPD:56526   ALP   alkaline phosphatase (plasma ALP)   [IU/L]  
Measures • age 16-17wks    • 20-21wks
Data set, strains GMC16   inbred w/CC8   8 strains     sex: both
Procedure metabolic panel
Comparisonmultiple cohorts measured at two age timepoints
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

GMC16 - alkaline phosphatase (plasma ALP)





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 1 10737.4824 10737.4824 5.6231 0.0192
sex 1 48842.6797 48842.6797 25.5782 < 0.0001
strain 4 45531.8688 11382.9672 5.9611 0.0002
age:sex 1 4247.0026 4247.0026 2.2241 0.1383
age:strain 4 6374.9095 1593.7274 0.8346 0.5056
sex:strain 4 33802.3262 8450.5815 4.4255 0.0022
age:sex:strain 4 2265.8893 566.4723 0.2967 0.8797
Residuals 128 244421.1591 1909.5403

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
GMC16 56526 metabolic panel (none) alkaline phosphatase (plasma ALP)   [IU/L]   at age 16-17wks  ALP_17 inbred w/CC8 7 both 16-17wks
GMC16 56527 metabolic panel (none) alkaline phosphatase (plasma ALP)   [IU/L]   at age 20-21wks  ALP_21 inbred w/CC8 8 both 20-21wks